The last two are interesting to me. There are a lot of CBD companies who will need to upgrade everything they are doing to comply with coming change in FDA regulations, and that could be a business in itself. Stuff like labeling, CBD quality, marketing, etc
The last, being a bridge between CBD companies and funding sources in New York. This could position them to take positions in other CBD stocks and generate cash by selling those company shares. Also could allow them to take larger equity stakes in any new CBD plays that go public through them.
That alone could cover basic monthly overhead if they can they 1) can close few new deals, and 2) partner with some funding sources in city
Have a great low float, or killer chart to share with our group of traders? Post it up on my new board!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.